Arbor Biotechnologies logo

Arbor Biotechnologies Funding & Investors

Cambridge, MA

Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

arbor.bio

Total Amount Raised: $304,500,000

Arbor Biotechnologies Funding Rounds

  • Series C

    $73,900,000

    Series C Investors

    Arch Venture Partners
    TCG Crossover Management
    Revelation Partners
    Partners Investment
    Qatar Investment Authority
    Ally Bridge Group
    ArrowMark Colorado Holdings
    Deep Track Capital
    Temasek Holdings
    T. Rowe Price
    Surveyor Capital
    Vertex Pharmaceuticals
    Piper Heartland Healthcare Capital
    Standard Life Aberdeen
    Kerna Ventures
  • Series B

    $215,000,000

    Series B Investors

    Ally Bridge Group
    TCG Crossover Management
    Temasek Holdings
    S32
    Woodline Partners
    Ridgeback Capital Management
    GreatPoint Ventures
    T. Rowe Price
    Henderson Global Investors
    Illumina Ventures
    Ono Venture Investment
    Vertex Pharmaceuticals
    Deep Track Capital
    Surveyor Capital
    Tekla Capital Management
    Arch Venture Partners
    Tao Capital Partners
    Logos Capital
    ArrowMark Colorado Holdings
  • Series A

    $15,600,000

    Series A Investors

    Arch Venture Partners
    Alexandria Real Estate Equities
Funding info provided by Diffbot.